Page last updated: 2024-08-21

nicotinamide mononucleotide and Left Ventricular Dysfunction

nicotinamide mononucleotide has been researched along with Left Ventricular Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gao, F; He, B; Huang, R; Wan, Y; Wang, C; Wang, L; Zhu, D; Zhu, J1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Left Ventricular Dysfunction

ArticleYear
Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
    Archives of biochemistry and biophysics, 2021, 11-15, Volume: 712

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Fibrosis; Heart; Inflammasomes; Inflammation; Male; Myocardium; Nicotinamide Mononucleotide; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats, Sprague-Dawley; Ventricular Dysfunction, Left

2021